Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antiviral Activity of Entecavir in Liver Transplant Recipients with Hepatitis B Virus
2006-000453-22Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of entecavir in Chronic Hepatitis B (CHB), sponsored by Bristol Myers Squibb. Primary endpoint: HBV virological recurrence at 72 weeks post-OLT. Started Feb 2007; status: completed.
02
Drugs
entecavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2006-000453-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000453-22.